BAYER STOPS SALES OF TRASYLOL GLOBALLY
Bayer AG has halted worldwide sales of its antibleeding drug Trasylol after a Canadian clinical study last month found that it could be linked to a higher risk of death than other drugs.
Bayer AG has halted worldwide sales of its antibleeding drug Trasylol after a Canadian clinical study last month found that it could be linked to a higher risk of death than other drugs.
No comments:
Post a Comment